XML 32 R7.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
ATM Offering Program
Registered Direct Offering
Revenue Interest Purchase Agreement
Total ImmunityBio Stockholders’ Deficit
Total ImmunityBio Stockholders’ Deficit
ATM Offering Program
Total ImmunityBio Stockholders’ Deficit
Registered Direct Offering
Total ImmunityBio Stockholders’ Deficit
Revenue Interest Purchase Agreement
Common Stock
Common Stock
ATM Offering Program
Common Stock
Registered Direct Offering
Common Stock
Revenue Interest Purchase Agreement
Additional Paid-in Capital
Additional Paid-in Capital
ATM Offering Program
Additional Paid-in Capital
Registered Direct Offering
Additional Paid-in Capital
Revenue Interest Purchase Agreement
Accumulated Deficit 
Accumulated Other Comprehensive Income
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2020                 382,243,142                    
Beginning balance at Dec. 31, 2020 $ (118,490)       $ (119,808)       $ 38       $ 1,495,163       $ (1,615,131) $ 122 $ 1,318
Increase (Decrease) in Statements of Stockholders’ Deficit [Roll Forward]                                      
Issuance of common stock, net (in shares)                   13,295,817                  
Issuance of common stock, net   $ 164,530       $ 164,530       $ 2       $ 164,528          
Stock-based compensation expense 57,181       57,181               57,181            
Exercise of stock options (in shares)                 1,695,638                    
Exercise of stock options 5,461       5,461               5,461            
Vesting of restricted stock units (RSUs) (in shares)                 873,058                    
Net share settlement for RSUs vesting (in shares)                 (277,611)                    
Net share settlement for RSUs vesting (4,064)       (4,064)               (4,064)            
Sales of assets to an entity under common control 1,435       1,435               1,435            
Gain on extinguishment of debt with related parties under common control 0                                    
Other comprehensive income (loss), net of tax (118)       (118)                         (118)  
Net loss (349,848)       (346,790)                       (346,790)   (3,058)
Ending balance (in shares) at Dec. 31, 2021                 397,830,044                    
Ending balance at Dec. 31, 2021 (243,913)       (242,173)       $ 40       1,719,704       (1,961,921) 4 (1,740)
Increase (Decrease) in Statements of Stockholders’ Deficit [Roll Forward]                                      
Issuance of common stock, net (in shares)                   2,051,894 9,090,909                
Issuance of common stock, net   13,129 $ 13,007     13,129 $ 13,007       $ 1     13,129 $ 13,006        
Issuance of common stock in exchange for notes payable (in shares)                 9,986,920                    
Issuance of common stock in exchange for notes payable (Note 10) 51,947       51,947       $ 1       51,946            
Stock-based compensation expense 40,179       40,179               40,179            
Exercise of stock options (in shares)                 14,767                    
Exercise of stock options 74       74               74            
Vesting of restricted stock units (RSUs) (in shares)                 521,296                    
Net share settlement for RSUs vesting (in shares)                 (156,011)                    
Net share settlement for RSUs vesting (616)       (616)               (616)            
Shares issued pursuant to litigation settlement (in shares)                 2,229,296                    
Shares issued pursuant to litigation settlement 10,656       10,656               10,656            
Gain on extinguishment of debt with related parties under common control 82,858       82,858               82,858            
Other comprehensive income (loss), net of tax 179       179                         179  
Net loss $ (417,320)       (416,567)                       (416,567)   (753)
Ending balance (in shares) at Dec. 31, 2022 421,569,115               421,569,115                    
Ending balance at Dec. 31, 2022 $ (449,820)       (447,327)       $ 42       1,930,936       (2,378,488) 183 (2,493)
Increase (Decrease) in Statements of Stockholders’ Deficit [Roll Forward]                                      
Issuance of common stock, net (in shares)                   5,605,323 28,641,911 2,432,894              
Issuance of common stock, net   $ 16,106 $ 36,931 $ 11,581   $ 16,106 $ 36,931 $ 11,581   $ 1 $ 3     $ 16,105 $ 36,928 $ 11,581      
Issuance of common stock in exchange for notes payable (in shares)                 209,291,936                    
Issuance of common stock in exchange for notes payable (Note 10) 269,987       269,987       $ 21       269,966            
Gain on debt extinguishment with related-parties under common control (Note 10) 36,110       36,110               36,110            
Increase in fair value of embedded conversion feature from debt modification with entities under common control (Note 10) 31,179       31,179               31,179            
Stock-based compensation expense $ 49,163       49,163               49,163            
Exercise of stock options (in shares) 184,362               184,362                    
Exercise of stock options $ 294       294               294            
Vesting of restricted stock units (RSUs) (in shares)                 4,545,644                    
Net share settlement for RSUs vesting (in shares)                 (1,403,841)                    
Net share settlement for RSUs vesting (3,443)       (3,443)               (3,443)            
Gain on extinguishment of debt with related parties under common control 36,110                                    
Change in ownership interest in a joint venture due to legal settlement (Note 7) 0       (4,199)               (4,199)           4,199
Other comprehensive income (loss), net of tax (173)       (173)                         (173)  
Net loss $ (583,852)       (583,196)                       (583,196)   (656)
Ending balance (in shares) at Dec. 31, 2023 670,867,344               670,867,344                    
Ending balance at Dec. 31, 2023 $ (585,937)       $ (586,987)       $ 67       $ 2,374,620       $ (2,961,684) $ 10 $ 1,050